Indian Journal of Endocrinology and Metabolism

ENDOCRINOLOGY AND GENDER
Year
: 2020  |  Volume : 24  |  Issue : 2  |  Page : 128--135

IDEA group consensus statement on medical management of adult gender incongruent individuals seeking gender reaffirmation as female


Anirban Majumder1, Sudip Chatterjee2, Debasis Maji2, Soumyabrata Roychaudhuri1, Sujoy Ghosh3, Chitra Selvan4, Belinda George5, Pramila Kalra4, Indira Maisnam6, Debmalya Sanyal1 
1 Department of Endocrinology, KPC Medical College and Hospital, Kolkata, India
2 Department of Medicine, Vivekananda Institute of Medical Sciences, Kolkata, India
3 Department of Endocrinology, Institute of Post-Graduate Medical Education and Research, Kolkata, India
4 Department of Endocrinology, MS Ramaiah Memorial Hospital, Bengaluru, India
5 Department of Endocrinology, St. John's Medical College Hospital, Bengaluru, India
6 Department of Endocrinology, R. G. Kar Medical College and Hospital, Kolkata, West Bengal, India

Correspondence Address:
Anirban Majumder
GB, CHHAYANEER, 26 A, Gariahat Road, Kolkata - 700 031, West Bengal
India

Cross sex hormone therapy (CSHT) is a strongly desired medical intervention for gender incongruent individuals. The goal is to change secondary sex characteristics to facilitate gender presentation that is consistent with the desired sex. When appropriately prescribed CSHT can greatly improve mental health and quality of life for gender incongruent individuals. Appropriate care for gender incongruent individuals in India is almost absent due to lack of country specific guideline and lack of training amongst the medical professionals. This document is intended to assist endocrinologists and physicians whose adult gender incongruent client is seeking gender reaffirmation as female (transfeminine). These individuals require a safe and effective CSHT regimen that will suppress endogenous male hormone secretion and maintain physiologic levels of female sex hormone. In this document, we offer suggestions based on an in-depth review of Guidelines of Endocrine Society, The World Professional Association for Transgender Health guidelines, the Sappho Good Practice Guide of India and collegial meetings with expert Indian clinicians working in this field. Clinicians represented in our expert panel are not gender specialists by training but have developed expertise due to the volume of gender incongruent individuals they manage. This consensus statement on medical management provides protocols for the prescribing clinician relating to diagnosis, baseline evaluation and counselling, prescription planning for feminizing hormone therapy and anti-androgen therapy, targets for monitoring hormone therapy, choice of therapy, clinical and biochemical monitoring, recommending sex reaffirmation surgery and peri-operative hormone therapy. The recommendations made in this document should not be perceived as a rigid set of guidelines and the treating clinicians are encouraged to modify our suggested protocols to address emerging issues.


How to cite this article:
Majumder A, Chatterjee S, Maji D, Roychaudhuri S, Ghosh S, Selvan C, George B, Kalra P, Maisnam I, Sanyal D. IDEA group consensus statement on medical management of adult gender incongruent individuals seeking gender reaffirmation as female.Indian J Endocr Metab 2020;24:128-135


How to cite this URL:
Majumder A, Chatterjee S, Maji D, Roychaudhuri S, Ghosh S, Selvan C, George B, Kalra P, Maisnam I, Sanyal D. IDEA group consensus statement on medical management of adult gender incongruent individuals seeking gender reaffirmation as female. Indian J Endocr Metab [serial online] 2020 [cited 2020 Jun 3 ];24:128-135
Available from: http://www.ijem.in/article.asp?issn=2230-8210;year=2020;volume=24;issue=2;spage=128;epage=135;aulast=Majumder;type=0